TMEM184A
gene geneOn this page
Also known as MGC9712SDMG1SLC51C1
Summary
TMEM184A (transmembrane protein 184A, HGNC:28797) is a protein-coding gene on chromosome 7p22.3, encoding Transmembrane protein 184A (Q6ZMB5). Acts as a heparin receptor in vascular cells.
Predicted to enable heparin binding activity and transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to act upstream of or within germ-line sex determination; regulation of protein localization; and regulation of secretion. Predicted to be located in cytoplasmic vesicle; perinuclear region of cytoplasm; and plasma membrane. Predicted to be active in early endosome membrane.
Source: NCBI Gene 202915 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 85 total
- MANE Select transcript:
NM_001097620
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28797 |
| Approved symbol | TMEM184A |
| Name | transmembrane protein 184A |
| Location | 7p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC9712, SDMG1, SLC51C1 |
| Ensembl gene | ENSG00000164855 |
| Ensembl biotype | protein_coding |
| Entrez | 202915 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 15 protein_coding, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000297477, ENST00000319010, ENST00000319018, ENST00000414730, ENST00000421923, ENST00000421996, ENST00000431208, ENST00000441933, ENST00000449955, ENST00000468535, ENST00000474813, ENST00000910336, ENST00000910337, ENST00000910339, ENST00000910340, ENST00000910342, ENST00000910344, ENST00000910345, ENST00000943039, ENST00000943040, ENST00000943041
RefSeq mRNA: 1 — MANE Select: NM_001097620
NM_001097620
CCDS: CCDS43537
Canonical transcript exons
ENST00000297477 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001239641 | 1542235 | 1547181 |
| ENSE00001650723 | 1555266 | 1555484 |
| ENSE00001767769 | 1556114 | 1556205 |
| ENSE00003509873 | 1548519 | 1548688 |
| ENSE00003521784 | 1550817 | 1550982 |
| ENSE00003536087 | 1547742 | 1547939 |
| ENSE00003637065 | 1549854 | 1549945 |
| ENSE00003669381 | 1550123 | 1550198 |
| ENSE00003787862 | 1550305 | 1550395 |
Expression profiles
Bgee: expression breadth ubiquitous, 230 present calls, max score 98.47.
FANTOM5 (CAGE): breadth broad, TPM avg 3.1632 / max 90.4549, expressed in 434 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 82430 | 0.8285 | 244 |
| 82429 | 0.5000 | 218 |
| 82433 | 0.4801 | 157 |
| 82431 | 0.4257 | 198 |
| 82427 | 0.3633 | 182 |
| 82428 | 0.3431 | 188 |
| 82426 | 0.1990 | 104 |
| 82432 | 0.0236 | 8 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 98.47 | gold quality |
| esophagus mucosa | UBERON:0002469 | 96.45 | gold quality |
| right uterine tube | UBERON:0001302 | 94.37 | gold quality |
| buccal mucosa cell | CL:0002336 | 93.20 | silver quality |
| vena cava | UBERON:0004087 | 92.76 | gold quality |
| skin of abdomen | UBERON:0001416 | 92.44 | gold quality |
| skin of leg | UBERON:0001511 | 91.85 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 91.33 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 90.96 | gold quality |
| parotid gland | UBERON:0001831 | 90.62 | gold quality |
| right lobe of liver | UBERON:0001114 | 90.48 | gold quality |
| body of pancreas | UBERON:0001150 | 90.14 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 89.76 | gold quality |
| zone of skin | UBERON:0000014 | 89.51 | gold quality |
| body of tongue | UBERON:0011876 | 88.05 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 87.85 | gold quality |
| cerebellar vermis | UBERON:0004720 | 87.81 | silver quality |
| duodenum | UBERON:0002114 | 87.32 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 87.12 | gold quality |
| minor salivary gland | UBERON:0001830 | 86.48 | gold quality |
| mouth mucosa | UBERON:0003729 | 86.18 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 85.98 | gold quality |
| vagina | UBERON:0000996 | 85.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.86 | gold quality |
| trachea | UBERON:0003126 | 85.84 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 85.81 | silver quality |
| tongue | UBERON:0001723 | 85.17 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 85.03 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 84.89 | gold quality |
| nipple | UBERON:0002030 | 84.71 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.03 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- TMEM184A functions as a heparin receptor and mediates anti-inflammatory responses of endothelial cells involving decreased JNK and p38 activity. (PMID:26769965)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem184a | ENSDARG00000104538 |
| mus_musculus | Tmem184a | ENSMUSG00000036687 |
| rattus_norvegicus | Tmem184a | ENSRNOG00000001275 |
| caenorhabditis_elegans | WBGENE00009574 |
Paralogs (3): SLC51A (ENSG00000163959), TMEM184C (ENSG00000164168), TMEM184B (ENSG00000198792)
Protein
Protein identifiers
Transmembrane protein 184A — Q6ZMB5 (reviewed: Q6ZMB5)
All UniProt accessions (7): B7WNT3, C9J4I0, C9JDD9, C9JKG9, Q6ZMB5, F8W8F1, F8WEG1
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a heparin receptor in vascular cells. May be involved in vesicle transport in exocrine cells and Sertoli cells.
Subcellular location. Cell membrane. Cytoplasm. Perinuclear region. Cytoplasmic vesicle membrane. Early endosome membrane. Endosome. Cytoplasmic vesicle. Secretory vesicle membrane.
Tissue specificity. Expressed in vascular cells (at protein level).
Similarity. Belongs to the TMEM184 family.
RefSeq proteins (1): NP_001091089* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005178 | Ostalpha/TMEM184C | Family |
Pfam: PF03619
UniProt features (12 total): transmembrane region 7, sequence variant 2, chain 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZMB5-F1 | 73.24 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 86 (showing top):
RNGTGGGC_UNKNOWN, GOCC_SECRETORY_GRANULE, GCANCTGNY_MYOD_Q6, CAGCTG_AP4_Q5, chr7p22, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, GOMF_GLYCOSAMINOGLYCAN_BINDING, RYTTCCTG_ETS2_B, GOMF_HEPARIN_BINDING, NIKOLSKY_BREAST_CANCER_7P22_AMPLICON, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_SECRETORY_VESICLE, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, GOCC_EARLY_ENDOSOME_MEMBRANE, GOCC_SECRETORY_GRANULE_MEMBRANE
GO Biological Process (1): transmembrane transport (GO:0055085)
GO Molecular Function (2): heparin binding (GO:0008201), transmembrane transporter activity (GO:0022857)
GO Cellular Component (10): endosome (GO:0005768), plasma membrane (GO:0005886), transport vesicle membrane (GO:0030658), cytoplasmic vesicle membrane (GO:0030659), secretory granule membrane (GO:0030667), early endosome membrane (GO:0031901), perinuclear region of cytoplasm (GO:0048471), cytoplasm (GO:0005737), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasmic vesicle | 2 |
| cytoplasmic vesicle membrane | 2 |
| bounding membrane of organelle | 2 |
| cytoplasm | 2 |
| transport | 1 |
| cellular process | 1 |
| glycosaminoglycan binding | 1 |
| sulfur compound binding | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| endomembrane system | 1 |
| membrane | 1 |
| cell periphery | 1 |
| transport vesicle | 1 |
| vesicle membrane | 1 |
| secretory granule | 1 |
| early endosome | 1 |
| endosome membrane | 1 |
| intracellular anatomical structure | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
540 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM184A | KCTD14 | Q9BQ13 | 607 |
| TMEM184A | TMEM190 | Q8WZ59 | 509 |
| TMEM184A | DNAI3 | Q8IWG1 | 502 |
| TMEM184A | TINAGL1 | Q9GZM7 | 467 |
| TMEM184A | OR56A3 | Q8NH54 | 445 |
| TMEM184A | ERICH4 | A6NGS2 | 443 |
| TMEM184A | TMEM128 | Q5BJH2 | 419 |
| TMEM184A | TMEM214 | Q6NUQ4 | 414 |
| TMEM184A | LRRCC1 | Q9C099 | 404 |
| TMEM184A | TRPV4 | Q9HBA0 | 377 |
| TMEM184A | AMBN | Q9NP70 | 362 |
| TMEM184A | INSL3 | P51460 | 352 |
| TMEM184A | TMEM245 | Q9H330 | 352 |
| TMEM184A | PARM1 | Q6UWI2 | 346 |
| TMEM184A | GSTO2 | Q9H4Y5 | 342 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM184A | SLC33A1 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM184A | AHNAK | psi-mi:“MI:0915”(physical association) | 0.400 |
| TMEM184A | RCHY1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TMEM184A | NRDC | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (118): TMEM184A (Affinity Capture-RNA), ALDH4A1 (Affinity Capture-MS), PDP2 (Affinity Capture-MS), HIBCH (Affinity Capture-MS), GTF2F2 (Affinity Capture-MS), ME2 (Affinity Capture-MS), YARS2 (Affinity Capture-MS), IBA57 (Affinity Capture-MS), KCTD15 (Affinity Capture-MS), RBM38 (Affinity Capture-MS), ASS1 (Affinity Capture-MS), RRM1 (Affinity Capture-MS), ISCU (Affinity Capture-MS), BAIAP2L1 (Affinity Capture-MS), NRD1 (Affinity Capture-MS)
ESM2 similar proteins: A2VDL9, A9UY97, F4JY11, G4YM00, G4Z2L3, O17204, O42579, P15920, P16393, P20715, P30628, P36142, P54960, P70549, P93766, Q09906, Q18071, Q1RMW2, Q29BL9, Q2U0S9, Q3UF25, Q3UFJ6, Q4QQS1, Q54PI4, Q54WM0, Q5BPZ5, Q5FWM8, Q5RBL0, Q5XIT3, Q5Z413, Q61086, Q651J5, Q657S5, Q6P6G5, Q6VVA6, Q6ZMB5, Q7TSW6, Q86TL2, Q8BG09, Q8MRQ4
Diamond homologs: A2VDL9, Q09906, Q17QL9, Q1RMW2, Q28CV2, Q3TPR7, Q3UFJ6, Q4QQS1, Q54PI4, Q54WM0, Q5BPZ5, Q5RET6, Q5ZMP3, Q6GQE1, Q6ZMB5, Q75JN3, Q810F5, Q8BG09, Q9NVA4, Q9Y519, F4JTN2, Q94CA0, P36142
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 6 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1975 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:1547002:T:TA | donor_gain | 1.0000 |
| 7:1548687:CA:C | acceptor_gain | 1.0000 |
| 7:1548689:C:CC | acceptor_gain | 1.0000 |
| 7:1549852:A:AC | donor_gain | 1.0000 |
| 7:1549853:C:CC | donor_gain | 1.0000 |
| 7:1550118:CTCA:C | donor_loss | 1.0000 |
| 7:1550121:A:C | donor_loss | 1.0000 |
| 7:1550122:CCT:C | donor_loss | 1.0000 |
| 7:1550303:A:AC | donor_gain | 1.0000 |
| 7:1550304:C:CC | donor_gain | 1.0000 |
| 7:1550392:AAGG:A | acceptor_gain | 1.0000 |
| 7:1550393:AGG:A | acceptor_gain | 1.0000 |
| 7:1550394:GG:G | acceptor_gain | 1.0000 |
| 7:1550396:C:CC | acceptor_gain | 1.0000 |
| 7:1550812:CCCA:C | donor_loss | 1.0000 |
| 7:1550813:CCAC:C | donor_loss | 1.0000 |
| 7:1550814:CA:C | donor_loss | 1.0000 |
| 7:1550815:ACC:A | donor_loss | 1.0000 |
| 7:1550978:TAGAT:T | acceptor_gain | 1.0000 |
| 7:1555260:GCTTA:G | donor_loss | 1.0000 |
| 7:1555261:CTTAC:C | donor_loss | 1.0000 |
| 7:1555262:TTAC:T | donor_loss | 1.0000 |
| 7:1555263:TAC:T | donor_loss | 1.0000 |
| 7:1555264:A:C | donor_loss | 1.0000 |
| 7:1555265:C:A | donor_loss | 1.0000 |
| 7:1546959:T:TA | donor_gain | 0.9900 |
| 7:1547182:C:CC | acceptor_gain | 0.9900 |
| 7:1547736:GTGTA:G | donor_loss | 0.9900 |
| 7:1547737:TGTA:T | donor_loss | 0.9900 |
| 7:1547739:TA:T | donor_loss | 0.9900 |
AlphaMissense
2680 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:1548637:G:C | S232R | 0.997 |
| 7:1548637:G:T | S232R | 0.997 |
| 7:1548639:T:G | S232R | 0.997 |
| 7:1550126:C:A | K183N | 0.996 |
| 7:1550126:C:G | K183N | 0.996 |
| 7:1549931:G:C | F189L | 0.995 |
| 7:1549931:G:T | F189L | 0.995 |
| 7:1549933:A:G | F189L | 0.995 |
| 7:1549938:A:G | L187P | 0.995 |
| 7:1550376:G:C | F135L | 0.995 |
| 7:1550376:G:T | F135L | 0.995 |
| 7:1550378:A:G | F135L | 0.995 |
| 7:1547096:G:C | N366K | 0.994 |
| 7:1547096:G:T | N366K | 0.994 |
| 7:1547107:C:G | A363P | 0.994 |
| 7:1550368:A:G | L138P | 0.994 |
| 7:1550379:G:C | S134R | 0.994 |
| 7:1550379:G:T | S134R | 0.994 |
| 7:1550381:T:G | S134R | 0.994 |
| 7:1550941:T:A | Q87H | 0.993 |
| 7:1550941:T:G | Q87H | 0.993 |
| 7:1547782:G:C | F324L | 0.992 |
| 7:1547782:G:T | F324L | 0.992 |
| 7:1547784:A:G | F324L | 0.992 |
| 7:1547824:G:C | C310W | 0.992 |
| 7:1549919:C:A | K193N | 0.992 |
| 7:1549919:C:G | K193N | 0.992 |
| 7:1549945:C:G | A185P | 0.992 |
| 7:1548547:T:A | K262N | 0.991 |
| 7:1548547:T:G | K262N | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000028094 (7:1552429 C>A,T), RS1000036040 (7:1544148 C>T), RS1000162679 (7:1555513 G>A,C), RS1000278337 (7:1555673 C>T), RS1000364926 (7:1547295 G>A,C), RS1000837108 (7:1548231 C>A,G,T), RS1000995920 (7:1544642 C>G,T), RS1001044505 (7:1555625 G>A), RS1001069436 (7:1551699 G>A), RS1001433605 (7:1551458 A>G), RS1001474082 (7:1554519 A>G), RS1001540697 (7:1551901 C>T), RS1001582978 (7:1547567 C>T), RS1001968638 (7:1551702 C>T), RS1002071299 (7:1555875 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects cotreatment, decreases expression | 2 |
| Cadmium Chloride | decreases expression, increases expression | 2 |
| FR900359 | decreases phosphorylation | 1 |
| bisphenol A | decreases methylation | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.